Design, Synthesis and Study of Nitrogen Monoxide Donors as Potent Hypolipidaemic and Anti-Inflammatory Agents
Open Access
Abstract
Inflammation and oxidative stress are involved in cardiovascular diseases. Nitrogen monoxide participates in the regulation of endothelial processes. Thus, derivatives of classic nonsteroidal anti-inflammatory drugs (NSAIDs), trolox or cinnamic acids esterified with 2-(nitrooxy)ethanol were designed and studied. It was found that the nitrogen monoxide (NO) releasing activity was comparable to that of S-nitroso-N-acetylpenicillamine. The nitrooxy derivatives decreased potently lipid indices in the plasma of hyperlipidaemic rats (30–85%). All compounds presented increased anti-inflammatory activity in vivo, inhibiting carrageenan-induced rat paw oedema as high as 76%, up to six times higher than that of the parent acids. Lipoxygenase inhibitory activity was significant for most of them, although the parent molecules exerted a minor effect (IC50 > 0.2 mM). Those compounds incorporating an antioxidant structure inhibited rat microsomal membrane lipid peroxidation strongly and possessed radical scavenging activity. These results indicated that the described compounds could act at different targets in multifactorial diseases, further limiting the possible adverse effects of drug combinations.Keywords
This publication has 29 references indexed in Scilit:
- Emerging role of 12/15-Lipoxygenase (ALOX15) in human pathologiesProgress in Lipid Research, 2019
- Medicinal Chemistry Approaches of Controlling Gastrointestinal Side Effects of Non-Steroidal Anti-Inflammatory Drugs. Endogenous Protective Mechanisms and Drug DesignMedicinal Chemistry, 2017
- Evaluating the Oxidative Stress in Inflammation: Role of MelatoninInternational Journal of Molecular Sciences, 2015
- 12- and 15-lipoxygenases in adipose tissue inflammationProstaglandins & Other Lipid Mediators, 2013
- Nitric oxide synthases: regulation and functionEuropean Heart Journal, 2011
- Mechanisms underlying recoupling of eNOS by HMG-CoA reductase inhibition in a rat model of streptozotocin-induced diabetes mellitusAtherosclerosis, 2008
- Nitrooxyethylation Reverses the Healing‐Suppressant Effect of IbuprofenMediators of Inflammation, 2006
- Nitric oxide releasing derivatives of tolfenamic acid with anti-inflammatory activity and safe gastrointestinal profileBioorganic & Medicinal Chemistry, 2005
- Lipoxygenases at the heart of atherosclerosis susceptibilityEuropean Journal of Human Genetics, 2004
- Statin-Sensitive Dysregulated AT1 Receptor Function and Density in Hypercholesterolemic MenCirculation, 1999